Ligand validation:5IJD

LP4: 2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-4-O-phosphono-beta-D-glucopyranose

LP4 is a Ligand Of Interest in 5IJD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5IJD_LP4_C_204	54%	35%	0.159	0.936	0.79	1.75	2	13	0	0	94%	0.9375
5IJD_LP4_D_804	49%	37%	0.173	0.933	0.88	1.59	2	8	1	0	94%	0.9375
3VQ1_LP4_D_300	52%	57%	0.174	0.943	0.72	0.94	-	2	3	0	94%	0.9375
3VQ2_LP4_D_300	43%	53%	0.195	0.93	0.68	1.13	-	4	0	0	94%	0.9375
4G8A_LP4_D_202	59%	42%	0.153	0.946	0.8	1.42	2	8	3	0	94%	0.9375
2E59_LP4_A_601	32%	49%	0.178	0.854	0.77	1.18	1	4	7	0	98%	0.9792
4LKV_LP4_A_402	18%	25%	0.245	0.917	1.12	1.91	1	7	1	0	54%	0.5417

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.